Reverse transcriptase substitution at codons 208 and 228 among treatment-experienced HIV-1 subtype-C-infected Indian patients is strongly associated with thymidine analogue mutations

J Acquir Immune Defic Syndr. 2012 Feb 1;59(2):e26-7. doi: 10.1097/QAI.0b013e31823e2d2b.

Abstract

In HIV-1 subtype C infected populations in south India, we searched for novel mutations associated with failing antiretroviral therapy that included nucleoside reverse transcriptase (RT) inhibitors. HIV-1 RT sequences were generated from treated and untreated groups and each nucleotide position was analysed with appropriate corrections for multiple testing. We found that nonsynonymous mutations at positions 208 and 228 were strongly associated with the presence of thymidine analogue mutations in the treated group, and were not present at all in the naïve group. The role of these substitutions on treatment outcomes and the evolution of drug resistance in HIV-1 subtype-C infected populations warrant further investigation.

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Substitution*
  • Codon / genetics*
  • DNA Mutational Analysis
  • DNA, Viral / genetics
  • Drug Resistance, Viral / genetics
  • HIV Infections / drug therapy
  • HIV Infections / genetics*
  • HIV Reverse Transcriptase / genetics*
  • HIV-1 / drug effects
  • HIV-1 / enzymology
  • HIV-1 / genetics*
  • Humans
  • India
  • Logistic Models
  • Reverse Transcriptase Inhibitors / therapeutic use
  • Thymidine
  • Treatment Failure

Substances

  • Codon
  • DNA, Viral
  • Reverse Transcriptase Inhibitors
  • HIV Reverse Transcriptase
  • Thymidine